Don't miss a moment from Paris-Roubaix and Unbound Gravel, to the Giro d’Italia, Tour de France, Vuelta a España, and everything in between when you join Outside+.
Speaking to VeloNews in a telephone interview, Froome admitted that the Salbutamol case was more of a distraction than he wanted to admit.
“If I am honest with myself, it was definitely a distraction for me and my preparation going into the Tour de France,” Froome said. “When you have something like that going on in the sidelines, it does take a lot of energy and focus when you’re meant to be thinking about preparation and recovery.”
Froome’s comments to VeloNews, as part of a larger interview looking back at his 2018 season that will be featured in an upcoming print edition, reveal just how much the Salbutamol case affected him both on and off the bike.
Froome was eventually cleared just days before the start of the 2018 Tour, but the emotional drain took its toll. Froome fell short of winning a record-tying fifth yellow jersey, while Sky teammate Geraint Thomas rode to victory in Paris.
Froome’s case dragged on for months once it was leaked to the media last December and dominated headlines throughout the season. Froome defied calls to step down as the case played out and doggedly won the Giro d’Italia with a dramatic, late-race coup. Though he put up a strong public face of a mix of defiance and business as usual, he admitted the building tension and stress played a negative factor throughout his season.
“The racing always takes preference, but it’s only natural that you read what the media is writing and what people are saying,” Froome continued. “I was extremely grateful of getting to the Tour and have the ruling before the race started. At least from that side of it, I could draw a line and begin the race with more tranquility.”
Froome, 33, stopped short of saying the ongoing drama cost him a record-tying fifth yellow jersey and was quick to tip his hat to Thomas. But he admitted the burden of the case and the possibility of a racing ban weighed heavily on him the closer the got to the Tour.
Though some critics accuse Froome of doing much worse than Salbutamol, an asthma treatment allowed under certain conditions by the WADA code, the Sky rider insists he is racing and winning within the rules.
“It was tough, really tough,” Froome continued. “Especially when my credibility as a clean sportsman was questioned. That is something that I hold quite dear to myself.
“I feel as if I live by my principles, and to have everything questioned over something like Salbutamol, it was frustrating,” he continued. “A lot of people didn’t understand what was going on. A lot of people didn’t understand the testing around Salbutamol. As frustrating as it was, it is not going to stop me from doing what I do. There was nothing untoward, and that was shown by the end of the case.”
Sky still hasn’t spelled out its 2019 racing program, but Froome said he is relieved that the Salbutamol case won’t be hanging over his upcoming campaign like it was during the past several months.